AUROBINDO PHARMA
Back to Balance Sheet
|
AUROBINDO PHARMA Last 5 Year Net Current Assets History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Net Current Assets (Including Current Investments) | ₹12,480 Cr | ₹11,573 Cr | ₹9,966 Cr | ₹9,888 Cr | ₹9,075 Cr |
What is the latest Net Current Assets ratio of AUROBINDO PHARMA ?
Year | Net Current Assets |
---|---|
Mar2025 | ₹12,480 Cr |
Mar2024 | ₹11,573 Cr |
Mar2023 | ₹9,966 Cr |
Mar2022 | ₹9,888 Cr |
Mar2021 | ₹9,075 Cr |
How is Net Current Assets of AUROBINDO PHARMA Trending?
Years | Net Current Assets | % Change | |
---|---|---|---|
Mar2025 | ₹12,480 Cr | 7.84 | |
Mar2024 | ₹11,573 Cr | 16.12 | |
Mar2023 | ₹9,966 Cr | 0.79 | |
Mar2022 | ₹9,888 Cr | 8.96 | |
Mar2021 | ₹9,075 Cr | - |
Compare Net Current Assets of peers of AUROBINDO PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
AUROBINDO PHARMA | ₹60,127.3 Cr | 0.7% | -5.1% | -33.4% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹379,659.0 Cr | -0.7% | -3.6% | -13.1% | Stock Analytics | |
DIVIS LABORATORIES | ₹162,886.0 Cr | 0.3% | -5.5% | 22.4% | Stock Analytics | |
CIPLA | ₹127,435.0 Cr | -0.8% | 4.1% | -4.1% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹121,719.0 Cr | 1.1% | -0.5% | 5.2% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹104,610.0 Cr | -0.8% | 2.3% | -8.1% | Stock Analytics |
AUROBINDO PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
AUROBINDO PHARMA | 0.7% |
-5.1% |
-33.4% |
SENSEX | 0.8% |
0.2% |
-2% |
You may also like the below Video Courses